Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3Phase 1 2Phase 4 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 9INDUSTRY 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 685Breast Neoplasms 584Neoplasms 468Colorectal Neoplasms 298Prostatic Neoplasms 262Neoplasm Metastasis 256Melanoma 241Ovarian Neoplasms 228Recurrence 216Lung Neoplasms 203Multiple Myeloma 195Lymphoma, Non-Hodgkin 155Pancreatic Neoplasms 154Leukemia, Myeloid, Acute 141Carcinoma, Hepatocellular 141Stomach Neoplasms 137Lymphoma 131Carcinoma, Renal Cell 128Glioblastoma 118Head and Neck Neoplasms 112Squamous Cell Carcinoma of Head and Neck 111Lymphoma, Follicular 106Leukemia, Lymphocytic, Chronic, B-Cell 99Lymphoma, Large B-Cell, Diffuse 96Leukemia 96Small Cell Lung Carcinoma 95Brain Neoplasms 91Carcinoma 82Uterine Cervical Neoplasms 76Triple Negative Breast Neoplasms 72

Interventions

ruxolitinib 1atezolizumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Fibrosis × Clear all
NCT06096779 2026-05-04

Kirros

Genentech, Inc.

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT01981850 2022-01-05

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

Hoffmann-La Roche

Phase 2 Completed
125 enrolled 38 charts
Myeloid

Fibrosis, Polycythemia Vera, Primary Myelofibrosis

NCT01562821 2017-01-13

Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy

Novo Nordisk A/S

Phase 2 Completed
235 enrolled

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡